TARGACEPT, INC.

CLOSED

950 Reynolds Blvd, Winston Salem, North Carolina, United Stateswww.targacept.comPrivate

Part of Gyre Therapeutics

Clinical Trials

3 active

Approvals

Total approvals

Agencies

Regulatory bodies

Founded

N/A

Overview

Trial Phase Distribution

Phase

Trials

Phase 2

63.2%

Phase 1

21.1%

Trial Status Distribution

Active, not recruiting

15.8%

Completed

79.0%

Terminated

5.3%

Clinical Trials

Trials sponsored by this organization (19)

Study Evaluating the Effect of TC-6499 on Gastric Emptying Time in Diabetic Subjects With Gastroparesis

Phase 1

Completed

interventional

Jun 201480 participants

Study Evaluating the Safety, Tolerability, and Efficacy of Dexmecamylamine (TC-5214) for Treatment of Overactive Bladder

Phase 2

Completed

interventional

May 20131,635 participants

A Clinical Trial to test whether TC-5619 improves symptoms for patients with stable schizophrenia if it is taken together with existing medicines.

Active, not recruiting

Apr 2012456 participants

Efficacy, Safety, and Tolerability of TC-5619 as Augmentation Therapy to Improve Negative Symptoms and Cognition in Outpatients With Schizophrenia

Phase 2

Completed

interventional

Dec 2011603 participants

Safety & Efficacy of TC-5619 in Adults With Inattentive-predominant Attention Deficit/Hyperactivity Disorder (ADHD)

Phase 2

Completed

interventional

Nov 2011250 participants

Efficacy, Safety, & Tolerability of AZD3480 Patients With Mild to Moderate Dementia of the Alzheimer's Type (AD)

Phase 2

Completed

interventional

Oct 2011386 participants

ot applicable

Active, not recruiting

Jul 2011300 participants

ot applicable

Active, not recruiting

interventional

Jun 2011300 participants

Page 1 of 3

Approvals

No approval data available

News

No news articles found

Back to Organizations